Jade Biosciences, Inc. Common Stock JBIO Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 14.3×-17.7× | 21.1×+15.3× | 9×+0.2× | 10.3×+3.8× | 32×+25.4× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $5.13+119% | $10.60+171% | $4.53+185% | $7.09+2,363,000% | -$26.46-909% | |
| Valuation | ||||||
| Market capitalization | $1.33B+318% | —— | —— | —— | —— | |
| Price / book | 4.5×— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Jade Biosciences, Inc. Common Stock's ratios come from?
- Every ratio is computed from Jade Biosciences, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.